Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>News>This Article

Melinjo Dimer Resveratrol can have Positive Effect Against Gout

Published: Monday, January 27, 2014
Last Updated: Monday, January 27, 2014
Bookmark and Share
Decreases serum uric acid levels in humans by increasing HDL cholesterol.

According to a clinical trial conducted by the Juntendo School of Medicine in Tokyo Japan, Melinjo Dimer Resveratrol decreases serum uric acid levels in humans.

This randomized controlled study demonstrated Melinjo Dimer Resveratrol beneficial effects in healthy adult males.

Compared with the placebo control, Melinjo Dimer Resvetarol significantly reduced serum uric acid levels and improved lipid metabolism by increasing HDL cholesterol.

The study was conducted by a group of scientist from the Juntendo School of Medicine in Tokyo. The study was double-blinded, randomized controlled study including 30 healthy males.

Compared with the placebo control, Melinjo Dimer Resvetarol significantly reduced serum uric acid levels and improved lipid metabolism by increasing HDL cholesterol.

Gout or the “rich man’s disease” has become more common in the recent years and is affecting about 1–2% of the Western population at some point in their lives. This rise is believed due to increasing risk factors in the population, such as metabolic syndrome, longer life expectancy and changes in diet and an increase in diseases associated with gout, such as high blood pressure. With the rising living standards globally gout has also become more common in other geographical areas, for example in China.

Gout is a medical condition characterized by acute inflammatory arthritis-a red, tender, hot, swollen joint. The most commonly affected joint is at the base of big toe; approximately 50% of cases are suffering of the podagra - “rich man’s disease in a poor man’s toe”.

Gout is caused by elevated levels of uric acid in the blood. The uric acid crystallizes, and the crystals deposit in joints, tendons, and surrounding tissues. Treatments are lifestyle changes and medical treatment with anti-inflammatory drugs.

Melinjo Dimer Resveratrol has demonstrated in previous trials its strong anti-inflammatory effect and this was the first human study demonstrating the positive effect on uric acid levels in humans.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Scroll Up
Scroll Down

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos